Navigation Links
Monsanto and Devgen Describe New Approach to Insect-Protection
Date:11/4/2007

ST. LOUIS, Nov. 4 /PRNewswire-FirstCall/ -- Scientists at Monsanto Company working in collaboration with Devgen NV, have identified an innovative and precise approach to protect crops against insects, which models a novel application of a Nobel Prize winning discovery. The technology is expected to provide farmers with a new in-the-seed option to protect crop yields and present another tool to support agriculture's mission of meeting the world's growing food, feed and fuel demands.

The results of the companies' research were published in the November edition of the peer-reviewed scientific journal Nature Biotechnology. The published scientific paper is a result of both individual work at Monsanto and Devgen as well as a collaborative research and development effort between Monsanto and Devgen.

The enabling technology, called RNA interference or RNAi, is a biological mechanism found in nature as a way to regulate gene expression. Monsanto identified novel applications of RNAi, enabling plants to be better protected against insect pests that feed on crops and impact yield.

"RNA interference is an incredibly promising method for crop improvement overall," said Robert T. Fraley, Ph.D., Monsanto executive vice president and chief technology officer. "Because of its specificity, this exciting technology can help us in areas of plant science that until now have simply not been possible."

"This technology has the ability to effectively control very specific plant pests," said Thierry Bogaert, CEO of Devgen. "This is a breakthrough in crop protection."

The research is expected to allow scientists to harness the cell's natural ability to regulate protein production and apply it to produce insect protection for the plant. Monsanto scientists are working on incorporating this promising application of RNAi into one of the company's future insect-protected corn projects.

"Future products in our research-and-development pipeline such as t
'/>"/>

SOURCE Monsanto Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Describe your invention, or your biotech patent may be worthless
2. Federal advisor to HHS describes the national information infrastructure
3. Acrylamide Polymerization A Practical Approach
4. Separation and Comparison of Proteins From Virulent and Nonvirulent Strains of the Fish Pathogen Flavobacterium psychrophilum, Using a 2-D Electrophoretic Approach
5. Simple Approaches for Optimization of RT-PCR
6. Kind approach to leveraging biofuels
7. American Family CIO takes entrepreneurial approach to innovation
8. RFID expert says piecemeal approach wont work
9. New nanotech approach could enable fast anthrax detection
10. Three Wisconsin approaches to technology transfer and commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 EquitiesIQ, a ... Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical company ... the wound care market. , Free report download: ... with a seasoned management team and Board, which launched ...
(Date:1/14/2014)... MA (PRWEB) January 14, 2014 iLab Solutions, ... Detwiler as the new Director of Product Strategy. In this ... well as iLab sub-teams to guide in the development of ... iLab provides the maximum possible benefit to the scientific community ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Class Group of AdvisorsSAN DIEGO, April 20 Trius ... Advisory Board, naming Donald H. Batts, MD, FACP, FIDSA, ... seventh members of the group of anti-infective thought leaders. ... Michigan State University and the Chief of ...
... at 100th Annual Meeting of the American Association for ... from Dendreon Corporation (Nasdaq: DNDN ) presented ... Cancer Treatment) or P-11 Phase 3 study suggesting that ... durable and can be maintained following boosting. The results ...
... have discovered a way to use an ancient life form ... in systems that may be surprisingly simple to build compared ... These tiny, single-celled marine life forms have existed for at ... of the life in the oceans, but they also have ...
Cached Biology Technology:Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board 2Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 2Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 3Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 4Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer 5Ancient diatoms lead to new technology for solar energy 2
(Date:4/18/2014)... Seeds that sprout as soon as they,re planted may be ... be more careful. In the wild, a plant whose seeds ... risk disaster. More than just an insurance policy against late ... dormancy has long-term advantages too: Plants whose seeds put ... more species, finds in a team of researchers working at ...
(Date:4/17/2014)... under clinical trials to treat tuberculosis could be the ... against various bacteria, fungal infections and parasites, yet evade ... chemists and collaborators. , Led by U. of I. ... ways the drug SQ109 attacks the tuberculosis bacterium, how ... from yeast to malaria and how targeting multiple ...
(Date:4/17/2014)... Foundation has been named awardee of a three-year ... Defense Spinal Cord Injury Research Program. Gail Forrest, ... double-blinded, controlled, multi-site clinical trial, which will test ... spinal cord injury. Dr. Forrest is assistant director ... Foundation. Two additional sites will participate - the ...
Breaking Biology News(10 mins):Plants with dormant seeds give rise to more species 2Multitarget TB drug could treat other diseases, evade resistance 2Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2
... deafness. , As a leader in stem cell-based research on the ... got a step-by-step plan for making this dream a reality. ... anyone can do it, he's the guy to place your ... this?'" said Heller, PhD, associate professor of otolaryngology, whose accent ...
... all remember a time when we were paralyzed in the ... world, making the right choice can mean the difference between ... choose the thing that leads to a "reward," such as ... and understanding those changes has been the focus of Natural ...
... Your bird field guide may be out of date now ... frogmouth bird on a South Pacific island. , New ... per year is announced globally. David Steadman and Andrew Kratter, ... the surprising new discovery on a collecting expedition in the ...
Cached Biology News:Stem cell transplants explored at Stanford as a possible treatment for hearing loss 2Stem cell transplants explored at Stanford as a possible treatment for hearing loss 3Rewarding fat rats 2UF scientists discover new genus of frogmouth bird in Solomon Islands 2UF scientists discover new genus of frogmouth bird in Solomon Islands 3
... high throughput, water bath thermal cycler capable of ... This equates to 9,216 reactions per run when ... rapidly transfers a basket of plates between three ... are considerably faster than those of peltier block ...
Proliferin (C-14)...
... Dideoxycytidine is a cytidine analog that has been ... Immunogen: Chemical / Small Molecule ... specificity of the ddC antiserum was determined by ... to moles of ddC analog at the 50% ...
The Holten Safe 2010 Class II Biological Safety Cabinets provide the most ergonomical working condition of comfort while incorporating the latest technology for safety, efficiency and performance....
Biology Products: